blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0550008

EP0550008 - Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.11.2000
Database last updated on 24.04.2024
Most recent event   Tooltip28.08.2009Change - representativepublished on 30.09.2009  [2009/40]
Applicant(s)For all designated states
LIFEGROUP S.p.A.
Viale Tre Venezie, 44/46
I-35043 Monselice (Padova) / IT
[1993/27]
Inventor(s)01 / Della Valle, Francesco
Via Cerato 14
I-35122 Padova / IT
02 / Lorenzi, Silvana
Piazza Napoli 17
I-35142 Padova / IT
03 / Marcolongo, Gabriele
Strada Interne, 5 Terra
I-35020 Carrara San Giorgia (Padova) / IT
[1993/27]
Representative(s)Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2009/40]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9
20122 Milano / IT
Former [1993/27]Gervasi, Gemma, Dr., et al
Studio Brevetti e Marchi NOTARBARTOLO & GERVASI S.r.l. 33, Viale Bianca Maria
I-20122 Milano / IT
Application number, filing date92121864.023.12.1992
[1993/27]
Priority number, dateIT1991MI0350931.12.1991         Original published format: IT MI913509
[1993/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0550008
Date:07.07.1993
Language:EN
[1993/27]
Type: A3 Search report 
No.:EP0550008
Date:07.12.1994
Language:EN
[1994/49]
Search report(s)(Supplementary) European search report - dispatched on:EP20.10.1994
ClassificationIPC:A61K31/16
[1993/27]
CPC:
A61K31/16 (EP); A61K31/165 (EP); A61K31/44 (EP);
A61K31/47 (EP); A61P11/00 (EP); A61P17/00 (EP);
A61P27/02 (EP); A61P27/14 (EP); A61P29/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P7/02 (EP);
C07C233/20 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/27]
TitleGerman:Verwendung von N-Acylderivaten von Aminoalkoholen mit Polycarbonsäuren zur Herstellung eines Arzneimittels zur Behandlung von Mastzellerkrankungen[1993/27]
English:Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells[1993/27]
French:Utilisation de dérivés N-acylés d'aminoalcools avec des acides polycarboxyliques pour la fabrication d'un médicament pour le traitement de maladies mastocytaires[1993/27]
Examination procedure29.05.1995Examination requested  [1995/32]
28.06.1996Despatch of a communication from the examining division (Time limit: M06)
30.12.1996Reply to a communication from the examining division
31.10.1997Despatch of a communication from the examining division (Time limit: M02)
30.12.1997Reply to a communication from the examining division
07.05.1999Despatch of a communication from the examining division (Time limit: M02)
08.07.1999Reply to a communication from the examining division
03.07.2000Application deemed to be withdrawn, date of legal effect  [2000/51]
25.07.2000Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2000/51]
Fees paidRenewal fee
23.12.1994Renewal fee patent year 03
22.05.1996Renewal fee patent year 04
22.05.1997Renewal fee patent year 05
29.12.1997Renewal fee patent year 06
04.01.1999Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.12.199504   M06   Fee paid on   22.05.1996
31.12.199605   M06   Fee paid on   22.05.1997
31.12.199908   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - V.ASTRAUSKAS ET AL., "Die Wirkung von antiphlogistischen und immunsuppressiven Präparaten auf Immunreaktionen und Eiweiss-Nukleinsäurestoffwechsel bei Adjuvansarthritis und experimentellen rheumatischen Prozessen", ALLERG. IMMUNOL., (1973), vol. 19, no. 2-4, pages 380 - 387 [X] 1,2,4,5,9 * abstract * * page 383 *
 [Y]  - JOANN M. MICAN ET AL., "Arthritis and mast cell activation", J.ALLERGY CLIN.IMMUNOL., (1990), vol. 86, no. 4(2), pages 677 - 683 [Y] 1-14 * abstract * * page 679, column R, paragraph 4 *
 [Y]  - HENRY C. POWELL ET AL., "Early changes in experimental allergic neuritis", LABORATORY INVESTIGATION, (1983), vol. 48, no. 3, pages 332 - 338 [Y] 1-14 * abstract * * page 332, column L *
 [Y]  - BARRY L. GRUBER, "Immunoglobulin E, mast cells, endogenous antigens, and arthritis", RHEUM. DIS. CLIN. NORTH. AM., (1991), vol. 17, no. 2, pages 333 - 342 [Y] 1-14 * abstract * * conclusion *; page 335, paragraph 3 *
 [Y]  - JOHN BIENENSTOCK ET AL., "Mast cell involvement in various inflammatory processes", AM. REV. RESP. DIS., (1987), vol. 135, no. 6(2), pages S5 - S8 [Y] 1-14 * abstract *
 [DY]  - KRÜGER PG ET AL., "Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures", ACTA NEUROL. SCAND., (1990), vol. 81, pages 31 - 36 [DY] 1-14 * abstract *
 [DY]  - F.A.KUEHL JR ET AL., "The identification of N-(2-hydroxyethyl)palmitamide as a naturally occuring anti-inflammatory agent", J. AM. CHEM. SOC., (1957), vol. 79, no. 19, pages 5577 - 5578 [DY] 1-14 * page 5577, column R, paragraph 4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.